On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
72° Feels Like: 72°
Wind: E 5 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Foggy 66°

Tomorrow

Cloudy 78°

Sun Night

Showers Late 65°

Alerts

Shire says new dry-eye drug fails to meet trial goal

LONDON (Reuters) - Drugmaker Shire said on Wednesday that its Lifitegrast treatment for adults with dry eye disease failed to meet one of two goals in a late-stage trial, the same result it saw in trial results in December. [ID:nL5N0JL1A5]

The drug met one goal for patient-reported symptoms of dry eye compared with placebo, the company said, but did not meet the second target based on signs of corneal staining.

Lifitegrast - a potential competitor for Allergan's Restasis, which is expected to have sales of around $900 million this year - is viewed as a key new product for Shire as it seeks to diversify its product line-up.

(Reporting by Paul Sandle; Editing by Brenda Goh)

Comments